Home Biosimilar Antibodies Others Others antibody Emicizumab (Anti-F9 / Factor IX) For research use only.
Not for use in humans.

Emicizumab (Anti-F9 / Factor IX)

Synonyms: null

Emicizumab (Anti-F9 / Factor IX) is a bispecific monoclonal antibody that bridges activated factor IX and factor X to replace the function of missing activated factor VIII, thereby restoring hemostasis. Emicizumab can be used for hemophilia A research. MW: 145.5 KD.

Emicizumab (Anti-F9 / Factor IX)

Purity & Quality Control

Biological Activity

Description Emicizumab (Anti-F9 / Factor IX) is a bispecific monoclonal antibody that bridges activated factor IX and factor X to replace the function of missing activated factor VIII, thereby restoring hemostasis. Emicizumab can be used for hemophilia A research. MW: 145.5 KD.

Product Details

CAS No. 1610943-06-0
Molecular Weight 145.5 kDa
Isotype Human IgG4SP
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Emicizumab (Anti-F9 / Factor IX) | Emicizumab (Anti-F9 / Factor IX) supplier | purchase Emicizumab (Anti-F9 / Factor IX) | Emicizumab (Anti-F9 / Factor IX) cost | Emicizumab (Anti-F9 / Factor IX) manufacturer | order Emicizumab (Anti-F9 / Factor IX) | Emicizumab (Anti-F9 / Factor IX) distributor